货号:
EY-3011K
保存条件:
Store at -20 °C
浓度:
1mg/1ml
应用范围:
产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
形态:
详见说明书
亚型:
IgG
免疫原:
KLH conjugated Synthesised phosphopeptide derived from human TAK1 around the phosphorylation site of Thr184
适应物种:
详见说明书
宿主:
详见说明书
标记物:
详见说明书
抗体名:
磷酸化转化生长因子β活化激酶1图片
抗体英文名:
Anti-Phospho-TAK1(Thr184)
保质期:
详见说明书
抗原来源:
Rabbit
克隆性:
多克隆
目录编号:
详见说明书
级别:
详见说明书
靶点:
详见说明书
数量:
60
供应商:
上海一研
规格:
0.1ml/100μg
公司专业供应的抗体,磷酸化转化生长因子β活化激酶1图片是用于化学反应、分析化验、研究实验、教学实 验、化学配方使用的纯净化学品,产品品质,价格实惠,多种规格供应,售后完善。英文名称 Anti-Phospho-TAK1(Thr184)中文名称 磷酸化转化生长因子β活化激酶1图片别 名 Mitogen-activated protein kinase kinase kinase 7; Transforming growth factor-beta-activated kinase 1; TGF-beta-activated kinase 1; MAP3K 7; MAPKKK7; Mitogen activated protein kinase kinase kinase 7; TAK1; TGF beta activated kinase 1; TGF1a; Transforming growth factor beta activated kinase 1; M3K7_HUMAN.浓 度 1mg/1ml规 格 0.1ml/100μg抗体来源 Rabbit克隆类型 polyclonal交叉反应 Human, Mouse, Rat, Chicken, Pig, Cow, Horse, Rabbit产品类型 一抗 磷酸化抗体研究领域 肿瘤 免疫学 信号转导 细胞凋亡 转录调节因子 激酶和磷酸酶蛋白分子量 predicted molecular weight:67kDa 性 状 Lyophilized or Liquid免 疫 原 KLH conjugated Synthesised phosphopeptide derived from human TAK1 around the phosphorylation site of Thr184亚 型 IgG纯化方法 affinity purified by Protein A储 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500(石蜡切片需做抗原修复)not yet tested in other applications.optimal dilutions/concentrations should be determined by the end user.保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.产品介绍 TAK1 (or MAP3K7) was shown to participate in regulation of transcription by transforming growth factor beta (TGF beta). TAK1 is stimulated in response to TGF beta and bone morphogenetic protein. These results suggest that TAK1 functions as a mediator in the signaling pathway of TGF beta superfamily members. TAB1 and TAB2 are TAK1 binding proteins that may function as activators of the TAK1 (TGF b activated kinase 1) MAPKKK in TGF b signal transduction. TAB1 induced TAK1 activation promoted the dissociation of active forms of IKKa and IKK b from active TAK1, whereas the IKK mutants remained to interact with active TAK1. TNF a activated endogenous TAK1, and the kinase negative TAK1 acted as a dominant negative inhibitor against TNF a induced NFkB activation. TAK1 was suggested to act as a regulatory kinase of IKKs.Function :Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR). Ceramides are also able to activate MAP3K7/TAK1. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs, c-jun N-terminal kinases (JNKs) and I-kappa-B kinase complex (IKK). Both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1), while nuclear factor-kappa B is activated by IKK. MAP3K7 activates also IKBKB and MAPK8/JNK1 in response to TRAF6 signaling and mediates BMP2-induced apoptosis. In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B. Promotes TRIM5 capsid-specific restriction activity. 磷酸化转化生长因子β活化激酶1图片几种抗体概述:1.抗角蛋白抗体(AKA),又称为抗丝集蛋白抗体或抗角质层抗体。AKA是类风湿关节炎早期诊断和判断预后的指标之一,其对RA患者的诊断的特异性为94% ,而其敏感性为47% ,并是一种鉴别RA和与多发性关节炎相关的丙型肝炎患者的有效检验标记物。2.抗核周因子( APF), 是定位于口腔黏附膜细胞胞质内的颗粒性蛋白复合物。可在RA患者的血清和关节液中测出,与性别、年龄无关。APF显示了较强的特异性(73%~99%)和敏感性。用间接免疫荧光法检测,方法精密度较差。3.抗环瓜氨酸肽抗体(CCP),具有相对好的敏感度和特异性。其实,抗核周因子和抗角蛋白抗体,与CCP在化学结构上具有相关性,它们的表位都含有瓜氨酸,称为瓜氨酸相关自身免疫系统。实验原理 :(1)特异性结合抗原:抗体本身不能直接溶解或杀伤带有特异抗原的靶细胞,通常需要补体或吞噬细胞等共同发挥效应以清除病原微生物或导致病理损伤。然而,抗体可通过与病毒或毒素的特异性结合,直接发挥中和病毒的作用。(2)活补体:IgM、IgG1、IgG2和IgG3可通过经典途径激活补体,凝聚的IgA、IgG4和IgE可通过替代途径激活补体。(3)结合细胞:不同类别的免疫球蛋白,可结合不同种的细胞,参与免疫应答。(4)可通过胎盘及粘膜:免疫球蛋白G(IgG)能通过胎盘进入胎儿血流中,使胎儿形成自然被动免疫。免疫球蛋白A(IgA)可通过消化道及呼吸道粘膜,是粘膜局部抗感染免疫的主要因素。(5)具有抗原性:抗体分子是一种蛋白质,也具有刺机体产生免疫应答的性能。不同的免疫球蛋白分子,各具有不同的抗原性。(6)抗体对理化因子的抵抗力与一般球蛋白相同:不耐热,60~70℃即被破坏。各种酶及能使蛋白质凝固变性的物质,均能破坏抗体的作用。抗体可被中性盐类沉淀。在生产上常可用硫酸铵或硫酸钠从免疫血清中沉淀出含有抗体的球蛋白,再经透析法将其纯化。AntibioticAgarNO.2MMO-MUG 100(g) incubation media MMO-MUG 100(g)酵母提取物琼脂 Yeast Extract Agar 250克 水中细菌总数的检测快速硫(H2S)试验琼脂250用于弯曲杆菌的硫试验(GB标准)incubationmedia快速硫(H2S)试验琼脂250用于弯曲杆菌的硫试验(GB标准)SodiumChlorideVioletpurpleEnrichmentBroth磷酸化转化生长因子β活化激酶1图片改良克氏双糖铁培养基250g生化培养基,用于小肠结肠炎耶尔森氏菌的生化反应筛选改良MSRV培养基 MSRV Medium,Modified 用于沙门氏的分离培养(MERCK方法)小牛浸膏粉 Beef extract powder 250克 BR含糖牛肉汤培养基250g/瓶用于乳酸菌培养和鉴别incubationmedia含糖牛肉汤培养基250g/瓶用于乳酸菌培养和鉴别Tergitol-7琼脂 250g 用于大肠菌群的鉴定(NMKL)